ADME-Toxicology Testing

World Market Report

MCP-7635

EXECUTIVE ENGAGEMENTS

POOL

3707
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

667
Interactions with Platform & by Email

PARTICIPANTS

111
Unique # Participated

VALIDATIONS

32
Responses Validated*

COMPANIES

79
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

192

PAGES

472

EDITION

17

PRICE

USD 5600

CODE

MCP-7635


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global ADME-Toxicology Testing Market to Reach $12.3 Billion by 2027
In the changed post COVID-19 business landscape, the global market for ADME-Toxicology Testing estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$12.3 Billion by 2027, growing at a CAGR of 10.9% over the analysis period 2020-2027. Cell Culture, one of the segments analyzed in the report, is projected to record a 13.4% CAGR and reach US$5.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the High Throughput Screening segment is readjusted to a revised 7.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 15.4% CAGR
The ADME-Toxicology Testing market in the U.S. is estimated at US$3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$966.9 Million by the year 2027 trailing a CAGR of 15.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 12.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.3% CAGR.Molecular Imaging Segment to Record 9.6% CAGR
In the global Molecular Imaging segment, USA, Canada, Japan, China and Europe will drive the 9.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$974.7 Million in the year 2020 will reach a projected size of US$1.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

SELECT PLAYERS

Agilent Technologies, Inc.; Beckman Coulter, Inc.; BioreclamationIVT, LLC; CompuDrug International, Inc.; Cyprotex PLC.; Eurofins ADME BIOANALYSES SAS; Molecular Discovery Ltd.; MultiCASE, Inc.; PerkinElmer, Inc.; Pharmaron, Inc.; Promega Corporation; Simulations Plus, Inc.; Taconic Biosciences, Inc.; Takara Bio Europe AB; Tecan Group Ltd.; Thermo Fisher Scientific, Inc.

SEGMENTS

» Technology (Cell Culture, High Throughput Screening, Molecular Imaging, OMICS, Other Technologies) » Method (Cellular Assay, Biochemical Assay, Ex-Vivo, In Silica) » Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Latin America » Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
ADME-Toxicology Testing – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
ADME-Tox : An Introduction
A Prelude to ADME Toxicology Testing
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
COVID-19 IMPACT ON ADME TOXICOLOGY TESTING MARKET
Global Market Prospects and Growth Drivers
Drug Makers Bet on ADME & Toxicology Testing to Improve Success Rate for Potential Drug Candidates
Cell Culture Holds a Major Share of the Market
North America and Europe Dominate, Asia-Pacific Witnesses Rapid Growth
Competition
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increased Need to Check Late-Stage Drug Failures Drive Market Growth
Exhibit: Steady Increase in Average Drug Development Cost and Efforts to Mitigate Late-Stage Drug Failure Rates Highlights the Role of ADME-Toxicology Testing: Average Cost of Drug Development (in US$ Billion) in the US since 1980s
Impact of ADME-Tox Screening on New Drug Discovery
TABLE 1: Phase-I Clinical Trial Failures Before and After the Advent of Preclinical ADME/Pharmacokinetics
EXHIBIT: actors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others
EXHIBIT: Drug Withdrawals Due to Toxicity Issues (1990-early 2010s): Percentage Share Breakdown of Number of Drugs Withdrawn Due to Cardiotoxicity, Hepatotoxicity and Others
Pharma Industry Renews Focus on Cost Optimization
EXHIBIT: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2011 through 2020
EXHIBIT: New FDA Approvals (2010-2020): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals
China and India: Hot Spots for R&D Investment
EXHIBIT: World R&D Market by Geographic Region (2020): Percentage Breakdown of R&D Spending for Asia, Europe, Middle East & Africa, North America and South America
Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge
Growing Prominence of Cell-based Assays in Drug Discovery and ADME Analysis
EXHIBIT: Global Cell-based Assays Market by Segment (2020): Percentage Share Breakdown of Value Sales for Consumables, Instruments, Software, and Services
EXHIBIT: Global Market for Cell-based Assays by End-User (2020): Percentage Share Breakdown of Value Sales for Pharma & Biotech Companies, Government & Academic Institutes, CROs, and Others
EXHIBIT: World Cell-based Assays Market by Application (2020): Percentage Breakdown of Revenue for ADME, Basic Research and Drug Discovery
Major Types of Cell-Based HTS Assays for Drug Screening
Cell-based Assays in HTS and UHTS
Innovation in Screening Guarantees Success for Drug Discovery Programs
High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays
High Content Screening - Key Application Areas
HCS Market Ripe with Growth Opportunity
HCS vs. HTS
Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing
3D Cell Culture Technology to Put a New Spin on In Vitro Cell Analyses
CDER’s DARS 2—Microphysiological 3D Cell Culture Platforms as Drug Development Tools
Rising Investment in Proteomics R&D Drive Cell-based Assays Market
Automated Multiplexing Platforms Present Growth Opportunities
Automation of Cell-based Assays: A Growing Trend
In-Silico ADME Emerge as Compelling Drug Discovery & Development Tool
Advantages of Using In Silico Approaches
Personalized Treatments & Computational Tools: Intriguing Facets of ADME R&D ADME Pharmacogenomics to Power Personalized Treatments
ADME Research & Emerging Computational Tools
Omics Technology
Adoption of Omics-based Technologies
In Vitro 3D Organoid Models to Meet ADME-Toxicity Testing Needs
Limitations of Traditional in vitro Cellular Models
Organoids Technology—Advanced in vitro 3D Platforms for More Physiologically Relevant Modeling
Stem Cells Exude Great Potential in Drug Toxicity Testing
Global Market for Stem Cell-Assays
Functional Assays: An Effective Way of Predicting Specific Toxic Effects
GPCR Targets to Drive Growth in Functional Cell Assay Market
Molecular Imaging and ADME
Organ-on-a-Chip Technology Gains Momentum in ADME Toxicology Testing
Technological Advancements in ADME Toxicology Testing
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for High Throughput Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Molecular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for OMICS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cellular Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biochemical Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Ex-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Ex-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Ex-Vivo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for In Silica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Systemic Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Renal Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Renal Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Renal Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Hepatotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hepatotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hepatotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Neurotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Neurotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Neurotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
UNITED STATES
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
JAPAN
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
CHINA
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
EUROPE
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
FRANCE
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
GERMANY
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
UNITED KINGDOM
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
RUSSIA
Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
ASIA-PACIFIC
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
LATIN AMERICA
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
MIDDLE EAST
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027
AFRICA
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com